MacroGenics | MGNX - Ebit





Ebit Изменить Дата
AbbVie USD 4.73B 1.08B 2026-03
Amgen USD 3.83B 130M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Biogen USD 514.3M 502.8M 2026-03
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Genmab DKK 260M 199M 2025-12
Geron USD -236K 10.55M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
J&J USD 6.62B 1.51B 2026-03
Karyopharm Therapeutics USD -17.84M 8.44M 2025-12
MacroGenics USD -12.1M 32.26M 2025-12
Merck USD -1.88B 8.12B 2026-03
Pfizer USD 4.99B 340M 2026-03
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Roche Holding CHF 9.56B 2.1B 2025-12
Xencor USD -77.86M 24.23M 2026-03